Chemoinformaics analysis of 1-[HYDROXY(4-HYDROXYPHENYL)METHYL]-6-METHOXYISOQUINOLIN-7-OL
| Molecular Weight | 297.31 | nRot | 3 |
| Heavy Atom Molecular Weight | 282.19 | nRig | 17 |
| Exact Molecular Weight | 297.1 | nRing | 3 |
| Solubility: LogS | -3.964 | nHRing | 1 |
| Solubility: LogP | 1.857 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 17 |
| nHA | 5 | APOL | 42.6999 |
| nHD | 3 | BPOL | 17.9241 |
| QED | 0.692 |
| Synth | 2.806 |
| Natural Product Likeliness | 0.883 |
| NR-PPAR-gamma | 0.736 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.169 |
| HIA | 0.078 |
| CACO-2 | -4.803 |
| MDCK | 0.00000697 |
| BBB | 0.046 |
| PPB | 0.929565 |
| VDSS | 0.808 |
| FU | 0.0607507 |
| CYP1A2-inh | 0.341 |
| CYP1A2-sub | 0.771 |
| CYP2c19-inh | 0.228 |
| CYP2c19-sub | 0.368 |
| CYP2c9-inh | 0.414 |
| CYP2c9-sub | 0.918 |
| CYP2d6-inh | 0.553 |
| CYP2d6-sub | 0.815 |
| CYP3a4-inh | 0.122 |
| CYP3a4-sub | 0.677 |
| CL | 6.289 |
| T12 | 0.816 |
| hERG | 0.054 |
| Ames | 0.473 |
| ROA | 0.16 |
| SkinSen | 0.864 |
| Carcinogencity | 0.127 |
| EI | 0.439 |
| Respiratory | 0.911 |
| NR-Aromatase | 0.886 |
| Antiviral | Yes |
| Prediction | 0.841517 |